TEM

+ Watchlist + Portfolio

Tempus AI, Inc.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $61.25
52-Week Range: $40.77 – $104.32
Market Cap: $12.03B
P/E (TTM): —
EPS (TTM): -1.44
Dividend Yield: —

Advanced Metrics

Price/Book: 26.97
PEG Ratio: —
Return on Equity: -67.44%
Return on Assets: -8.55%
Gross Margin: 63.98%
Operating Margin: -20.11%
Profit Margin: -17.77%
Current Ratio: 3.30
Debt/Equity: 3.25
Total Debt: $1.44B
Free Cash Flow: $-93.49M
Revenue Growth: 21.60%
Earnings Growth: —
Enterprise Value: $11.68B

TEM Income statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Revenue	$320.67M	$531.82M	$693.40M	$1.27B
Cost of Revenue	$190.48M	$245.65M	$312.29M	$473.89M
Gross Profit	$130.19M	$286.18M	$381.11M	$797.90M
Research & Development	$162.25M	$185.50M	$316.84M	$319.03M
Selling, General & Admin	$233.38M	$288.44M	$743.13M	$715.43M
Operating Expenses	$395.63M	$482.26M	$1.07B	$1.05B
Operating Income	-$265.44M	-$196.08M	-$691.08M	-$252.87M
EBITDA	-$236.85M	-$133.33M	-$610.42M	-$118.51M
Pretax Income	-$289.15M	-$213.53M	-$701.32M	-$291.10M
Income Tax	$66.00K	$288.00K	$266.00K	-$51.68M
Net Income	-$289.81M	-$214.12M	-$705.81M	-$245.03M
Diluted EPS	-5.26	-1.61	-6.23	-1.41
Diluted Shares	63.43M	164.83M	119.85M	174.26M

TEM Balance Sheet statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Cash & Equivalents	$302.94M	$165.77M	$340.95M	$604.79M
Receivables	$88.68M	$94.46M	$154.82M	$319.95M
Inventory	$22.28M	$28.84M	$38.39M	$51.72M
Current Assets	$438.63M	$350.33M	$667.60M	$1.17B
Total Assets	$631.36M	$564.05M	$926.12M	$2.27B
Current Liabilities	$174.24M	$232.63M	$291.07M	$372.39M
Long-Term Debt	$389.55M	$449.67M	$435.44M	$1.24B
Total Debt	$433.03M	$488.14M	$468.09M	$1.33B
Total Liabilities	$1.76B	$1.95B	$869.78M	$1.78B
Retained Earnings	-$1.14B	-$1.40B	-$2.15B	-$2.40B
Shareholders' Equity	-$1.13B	-$1.38B	$56.34M	$491.33M
Working Capital	$264.39M	$117.70M	$376.53M	$794.79M
Net Debt	$86.61M	$283.90M	$94.48M	$634.72M

TEM Cash Flow statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Operating Cash Flow	-$168.20M	-$214.34M	-$189.04M	-$218.09M
Capital Expenditure	-$18.38M	-$34.61M	-$22.12M	-$27.27M
Free Cash Flow	-$186.58M	-$248.95M	-$211.17M	-$245.35M
Depreciation & Amortisation	$30.41M	$33.33M	$37.24M	$102.32M
Stock-Based Compensation	$0.00	$0.00	$534.14M	$124.75M
Investing Cash Flow	-$57.94M	-$40.31M	-$130.39M	-$398.36M
Financing Cash Flow	$251.39M	$117.55M	$494.33M	$884.12M
Dividends Paid	-$5.63M	-$5.63M	-$5.63M	$0.00
Share Repurchases	$0.00	-$3.60M	-$2.25M	-$3.04M
Net Change in Cash	$25.25M	-$137.10M	$174.89M	$267.68M

TEM Income statement, quarterly periods, in USD
USD	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Revenue	$314.63M	$334.21M	$367.21M	$348.12M	$382.49M
Cost of Revenue	$119.60M	$124.26M	$129.50M	$126.08M	$135.99M
Gross Profit	$195.04M	$209.94M	$237.71M	$222.04M	$246.50M
Research & Development	$76.10M	$83.05M	$90.62M	$94.16M	$96.57M
Selling, General & Admin	$180.71M	$187.89M	$192.20M	$212.59M	$225.84M
Operating Expenses	$256.81M	$270.94M	$299.13M	$306.75M	$322.41M
Operating Income	-$61.77M	-$61.00M	-$61.41M	-$84.71M	-$75.91M
EBITDA	$9.08M	-$38.79M	-$14.81M	-$82.38M	$45.08M
Pretax Income	-$40.53M	-$81.22M	-$57.01M	-$122.89M	$8.81M
Income Tax	$212.00K	$276.00K	-$5.99M	-$62.00K	$309.00K
Net Income	-$42.84M	-$79.98M	-$54.17M	-$125.92M	$5.64M
Diluted EPS	-0.25	-0.46	—	-0.71	0.03
Diluted Shares	173.38M	174.94M	—	178.96M	182.40M

TEM Balance Sheet statement, quarterly periods, in USD
USD	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Cash & Equivalents	$186.31M	$655.92M	$604.79M	$521.17M	$599.61M
Receivables	$268.82M	$289.29M	$319.95M	$320.51M	$378.42M
Inventory	$47.60M	$54.98M	$51.72M	$51.83M	$53.51M
Current Assets	$644.20M	$1.15B	$1.17B	$1.05B	$1.29B
Total Assets	$1.63B	$2.28B	$2.27B	$2.14B	$2.37B
Current Liabilities	$418.16M	$350.03M	$372.39M	$317.96M	$391.49M
Long-Term Debt	$798.00M	$1.25B	$1.24B	$1.23B	$1.36B
Total Debt	$853.25M	$1.34B	$1.33B	$1.32B	$1.44B
Total Liabilities	$1.32B	$1.77B	$1.78B	$1.72B	$1.92B
Retained Earnings	-$2.26B	-$2.34B	-$2.40B	-$2.52B	-$2.52B
Shareholders' Equity	$309.56M	$507.82M	$491.33M	$416.40M	$444.93M
Working Capital	$226.04M	$796.48M	$794.79M	$735.99M	$899.37M
Net Debt	$611.70M	$589.76M	$634.72M	$712.00M	$761.10M

TEM Cash Flow statement, quarterly periods, in USD
USD	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Operating Cash Flow	$44.16M	-$119.84M	-$36.79M	-$73.28M	-$7.53M
Capital Expenditure	-$9.51M	-$8.05M	-$6.34M	-$10.07M	-$11.09M
Free Cash Flow	$34.65M	-$127.89M	-$43.12M	-$83.34M	-$18.62M
Depreciation & Amortisation	$28.03M	$27.03M	$26.91M	$26.18M	$25.99M
Stock-Based Compensation	$22.45M	$33.98M	$45.34M	$52.71M	$54.12M
Investing Cash Flow	-$9.51M	-$2.31M	-$10.72M	-$10.07M	-$11.09M
Financing Cash Flow	$0.00	$594.69M	-$3.61M	-$271.00K	$97.12M
Dividends Paid	—	$0.00	$0.00	—	—
Share Repurchases	—	$0.00	-$3.04M	—	—
Net Change in Cash	$34.65M	$472.54M	-$51.11M	-$83.61M	$78.50M

Market Snapshot

About

Tempus AI, Inc. is a technology company that has built the world largest library of clinical and molecular data and an operating system to make that data accessible and useful. The company uses artificial intelligence to personalize healthcare, starting with cancer care and expanding into other diseases. Tempus partners with physicians and researchers to provide precision medicine insights and enable data-driven clinical decisions.